Kernel
Kernel, a neuroscience company founded in 2016 and headquartered in Los Angeles, California, develops advanced brain-recording technologies aimed at enhancing human cognition. The company specializes in creating a non-invasive brain interface that captures neural signals with quality comparable to traditional imaging methods like fMRI and MEG, while being as user-friendly as EEG. Kernel's primary focus is on addressing dysfunctions linked to neurodegenerative diseases, offering neuroprosthetics that can mimic, repair, and improve cognitive functions. Additionally, the company provides access to brain imaging devices that enable remote experimentation, thereby furthering the understanding and treatment of neurological disorders.
MyTraffic
Series A in 2021
MyTraffic is a technology company that specializes in providing traffic data insights to enhance decision-making in the commercial real estate sector. The company has developed a big data platform that modernizes the location selection process for businesses and retailers by offering real-time marketing analysis and geo-targeting capabilities. Its solutions include access to various data types, such as pedestrian and vehicle traffic, socio-demographic profiles, and penetration rates. By leveraging data from social networks and analyzing external traffic, competition, and customer profiles, MyTraffic enables clients to identify optimal locations for their operations, helping them to maximize the potential of their stores.
Kendall Research Systems
Acquisition in 2017
Kendall Research Systems, LLC, established in 2011 and based in Cambridge, Massachusetts, specializes in developing hardware and software solutions for in vivo neuroscience research. The company is recognized for its innovative products including implantable optics, head-borne controllers, and wireless data access points and power transmitters. Its flagship offering, FireFly, is a comprehensive suite of optogenetics tools designed to support the needs of researchers in basic science and drug discovery. Originally a spin-out from MIT's Synthetic Neurobiology Lab, Kendall Research Systems was the first to commercialize a wireless optogenetics platform, with early access provided in 2012 and a full launch in 2015, backed by the National Institute of Health. In 2017, its implantable neurological device development was acquired by Kernel, but the company continues to leverage its expertise in applied physics, electrical engineering, and signal processing to address new challenges in healthcare and technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.